Showing results (41-50 of 1,477) with videos related to
Sort By:
Pageof 148
The Journal of Experimental Medicine|June 1, 1996
CTLA-4 ligation blocks CD28-dependent T cell activationT L Walunas, C Y Bakker, J A BluestoneJournal of Immunology (Baltimore, Md. : 1950)|January 15, 1991
Signal transduction through class I MHC by a monoclonal antibody that detects multiple murine and human class I moleculesB A Houlden, S M Widacki, J A BluestoneJournal of Immunology (Baltimore, Md. : 1950)|June 15, 1988
The alpha-3 domain of class I MHC proteins influences cytotoxic T lymphocyte recognition of antigenic determinants located within the alpha-1 and alpha-2 domainsR T Maziarz, S J Burakoff, J A BluestoneThe Journal of Experimental Medicine|May 1, 1986
Alloresistance to engraftment of allogeneic donor bone marrow is mediated by an Lyt-2+ T cell in mixed allogeneic reconstitution (C57BL/10Sn + B10.D2/nSn----C57BL/10Sn)S T Ildstad, J A Bluestone, D H SachsThe Journal of Experimental Medicine|October 1, 1987
A single amino acid substitution in the alpha 3 domain of an H-2 class I molecule abrogates reactivity with CTLT A Potter, J A Bluestone, T V RajanJournal of Immunology (Baltimore, Md. : 1950)|October 1, 1994
Insight into the mechanism of TCR-V beta 8+/CD8+ T cell-mediated MOPC-315 tumor eradicationM B Mokyr, A Prokhorova, M Rubin, et al.Annual Review of Cell and Developmental Biology|January 1, 1995
TCR gamma delta cells: a specialized T-cell subset in the immune systemJ A Bluestone, R Khattri, R Sciammas, et al.Journal of Immunology (Baltimore, Md. : 1950)|May 22, 2001
Mechanism of melphalan-induced B7-1 gene expression in P815 tumor cellsM Donepudi, P Raychaudhuri, J A Bluestone, et al.Cancer Research|December 16, 1998
Realization of the therapeutic potential of CTLA-4 blockade in low-dose chemotherapy-treated tumor-bearing miceM B Mokyr, T Kalinichenko, L Gorelik, et al.Science (New York, N.Y.)|October 28, 1988
In vivo administration of anti-CD3 prevents malignant progressor tumor growthJ D Ellenhorn, R Hirsch, H Schreiber, et al.Pageof 148